FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981053204> ?p ?o ?g. }

• W1981053204 endingPage "e11074" @default.
• W1981053204 startingPage "e11074" @default.
• W1981053204 abstract "Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults and carries a dismal prognosis. We have developed a conditional cytotoxic/immunotherapeutic approach using adenoviral vectors (Ads) encoding the immunostimulatory cytokine, human soluble fms-like tyrosine kinase 3 ligand (hsFlt3L) and the conditional cytotoxic molecule, i.e., Herpes Simplex Type 1- thymide kinase (TK). This therapy triggers an anti-tumor immune response that leads to tumor regression and anti-tumor immunological memory in intracranial rodent cancer models. We aim to test the efficacy of this immunotherapy in dogs bearing spontaneous GBM. In view of the controversy regarding the effect of human cytokines on dog immune cells, and considering that the efficacy of this treatment depends on hsFlt3L-stimulated dendritic cells (DCs), in the present work we tested the ability of Ad-encoded hsFlt3L to generate DCs from dog peripheral blood and compared its effects with canine IL-4 and GM-CSF.Our results demonstrate that hsFlT3L expressed form an Ad vector, generated DCs from peripheral blood cultures with very similar morphological and phenotypic characteristics to canine IL-4 and GM-CSF-cultured DCs. These include phagocytic activity and expression of CD11c, MHCII, CD80 and CD14. Maturation of DCs cultured under both conditions resulted in increased secretion of IL-6, TNF-alpha and IFN-gamma. Importantly, hsFlt3L-derived antigen presenting cells showed allostimulatory potential highlighting their ability to present antigen to T cells and elicit their proliferation.These results demonstrate that hsFlt3L induces the proliferation of canine DCs and support its use in upcoming clinical trials for canine GBM. Our data further support the translation of hsFlt3L to be used for dendritic cells' vaccination and gene therapeutic approaches from rodent models to canine patients and its future implementation in human clinical trials." @default.
• W1981053204 created "2016-06-24" @default.
• W1981053204 creator A5002866531 @default.
• W1981053204 creator A5018395957 @default.
• W1981053204 creator A5022723078 @default.
• W1981053204 creator A5027307535 @default.
• W1981053204 creator A5036408326 @default.
• W1981053204 creator A5039271498 @default.
• W1981053204 creator A5040421747 @default.
• W1981053204 creator A5040825774 @default.
• W1981053204 creator A5043155961 @default.
• W1981053204 creator A5053248713 @default.
• W1981053204 creator A5069775046 @default.
• W1981053204 creator A5073424560 @default.
• W1981053204 creator A5075433721 @default.
• W1981053204 creator A5080277287 @default.
• W1981053204 creator A5082380342 @default.
• W1981053204 creator A5084729731 @default.
• W1981053204 date "2010-06-11" @default.
• W1981053204 modified "2023-10-07" @default.
• W1981053204 title "Human Flt3L Generates Dendritic Cells from Canine Peripheral Blood Precursors: Implications for a Dog Glioma Clinical Trial" @default.
• W1981053204 cites W1504335832 @default.
• W1981053204 cites W1941906268 @default.
• W1981053204 cites W1967034772 @default.
• W1981053204 cites W1986880984 @default.
• W1981053204 cites W1993164532 @default.
• W1981053204 cites W1993467626 @default.
• W1981053204 cites W2001438994 @default.
• W1981053204 cites W2004540881 @default.
• W1981053204 cites W2017309872 @default.
• W1981053204 cites W2024051895 @default.
• W1981053204 cites W2029038516 @default.
• W1981053204 cites W2032213055 @default.
• W1981053204 cites W2036502394 @default.
• W1981053204 cites W2042084423 @default.
• W1981053204 cites W2044020062 @default.
• W1981053204 cites W2056475500 @default.
• W1981053204 cites W2061040171 @default.
• W1981053204 cites W2061159230 @default.
• W1981053204 cites W2063057320 @default.
• W1981053204 cites W2064662942 @default.
• W1981053204 cites W2073590543 @default.
• W1981053204 cites W2073746638 @default.
• W1981053204 cites W2094666071 @default.
• W1981053204 cites W2098850271 @default.
• W1981053204 cites W2103425166 @default.
• W1981053204 cites W2105100844 @default.
• W1981053204 cites W2113476117 @default.
• W1981053204 cites W2116126240 @default.
• W1981053204 cites W2127787180 @default.
• W1981053204 cites W2131702292 @default.
• W1981053204 cites W2141445393 @default.
• W1981053204 cites W2144434005 @default.
• W1981053204 cites W2148276738 @default.
• W1981053204 cites W2150876163 @default.
• W1981053204 cites W2151013400 @default.
• W1981053204 cites W2163172784 @default.
• W1981053204 cites W2168330082 @default.
• W1981053204 cites W2170366807 @default.
• W1981053204 doi "https://doi.org/10.1371/journal.pone.0011074" @default.
• W1981053204 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2884015" @default.
• W1981053204 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20552015" @default.
• W1981053204 hasPublicationYear "2010" @default.
• W1981053204 type Work @default.
• W1981053204 sameAs 1981053204 @default.
• W1981053204 citedByCount "30" @default.
• W1981053204 countsByYear W19810532042012 @default.
• W1981053204 countsByYear W19810532042013 @default.
• W1981053204 countsByYear W19810532042014 @default.
• W1981053204 countsByYear W19810532042015 @default.
• W1981053204 countsByYear W19810532042017 @default.
• W1981053204 countsByYear W19810532042018 @default.
• W1981053204 countsByYear W19810532042019 @default.
• W1981053204 countsByYear W19810532042020 @default.
• W1981053204 countsByYear W19810532042022 @default.
• W1981053204 countsByYear W19810532042023 @default.
• W1981053204 crossrefType "journal-article" @default.
• W1981053204 hasAuthorship W1981053204A5002866531 @default.
• W1981053204 hasAuthorship W1981053204A5018395957 @default.
• W1981053204 hasAuthorship W1981053204A5022723078 @default.
• W1981053204 hasAuthorship W1981053204A5027307535 @default.
• W1981053204 hasAuthorship W1981053204A5036408326 @default.
• W1981053204 hasAuthorship W1981053204A5039271498 @default.
• W1981053204 hasAuthorship W1981053204A5040421747 @default.
• W1981053204 hasAuthorship W1981053204A5040825774 @default.
• W1981053204 hasAuthorship W1981053204A5043155961 @default.
• W1981053204 hasAuthorship W1981053204A5053248713 @default.
• W1981053204 hasAuthorship W1981053204A5069775046 @default.
• W1981053204 hasAuthorship W1981053204A5073424560 @default.
• W1981053204 hasAuthorship W1981053204A5075433721 @default.
• W1981053204 hasAuthorship W1981053204A5080277287 @default.
• W1981053204 hasAuthorship W1981053204A5082380342 @default.
• W1981053204 hasAuthorship W1981053204A5084729731 @default.
• W1981053204 hasBestOaLocation W19810532041 @default.
• W1981053204 hasConcept C147483822 @default.
• W1981053204 hasConcept C154317977 @default.
• W1981053204 hasConcept C202751555 @default.
• W1981053204 hasConcept C203014093 @default.

• next